8 July 2022
James Cropper Plc
(the "Company")
Director Dealing
The Company has been notified on 7 July 2022 that on the same day, Phil Wild, a Director of the Company, purchased 2,280 ordinary shares of 25p each in the Company ("Shares") at a price of 877p per Share.
As a result, Phil Wild's beneficial interest in the Company has increased by 2,280 Shares.
Enquiries:
| James Cropper PLC (AIM: CRPR) Isabelle Maddock, Chief Financial Officer Jim Aldridge, Company Secretary Tel: +44 (0) 1539 722002 | Shore Capital Robert Finlay, Henry Willcocks John More Tel: + 44 (0) 20 7601 6100
|
The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:
| 1
| Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a)
| Names | Phil Wild | ||||||
| 2
| Reason for the notification | |||||||
| a)
| Position/status
| Director, Chief Executive Officer | ||||||
| b)
| Initial notification /Amendment | Initial Notification | ||||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a)
| Name | James Cropper plc | ||||||
| b)
| LEI | 213800XM78VTDYGBRM93 | ||||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a)
| Description of the financial instrument, type of instrument
| Ordinary Shares of 25p each | ||||||
| b) | Identification code
| GB0002346053 | ||||||
| c)
| Nature of the transaction
| Buy | ||||||
| d)
| Price(s) and volume(s) |
| ||||||
| d)
| Aggregated information - Aggregated volume - Price |
2,280 19,995.60 | ||||||
| e)
| Date of the transaction | 7 July 2022 | ||||||
| f)
| Place of the transaction | London Stock Exchange (XLON)
| ||||||
| | | | ||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.